LEXARIA BIOSCIENCE CORP. Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding
LEXARIA BIOSCIENCE CORP. (LEXX) had Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding of 200.00 thousand shares as of 2019-02-28, per its 10-Q filed 2019-04-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions · last filed 2019-07-08
- 2019-02-28: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding 200.00K shares.
- 2018-05-31: Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding 200.00K shares.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding |
|---|---|
| 2019-02-28 | 200.00K shares 10-Q · filed 2019-04-15 |
| 2018-05-31 | 200.00K shares 10-Q · filed 2019-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |